When vision fades: Rethinking wet AMD and the durability gap

<p>In this episode of Denatured, you’ll hear Philip Jacob Rosenfeld, professor of Ophthalmology at the University of Miami Health System and Bascom Palmer Eye Institute, and Wesley Jackson, chief science officer at Valitor. We talk about the eye condition call wet age-related macular degeneration (AMD), the limits of anti‑VEGF therapy and the push for true durability to change a patient’s life.</p><p></p><p><b>Host</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/jennifersmithparker/" target="_blank">Jennifer C. Smith-Parker</a>, Director of Insights, BioSpace</p><p></p><p><b>Guests</b></p><p><a rel="noopener noreferrer nofollow" href="https://theophthalmologist.com/power-list/2016/honorees/philip-j-rosenfeld/" target="_blank">Philip Jacob Rosenfeld</a>, Professor of Ophthalmology, University of Miami Health System, Bascom Palmer Eye Institute</p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/wesleymjackson/" target="_blank">Wesley Jackson</a>, Chief Science Officer, Valitor  </p><p></p><p><i>Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.</i></p>